We're not just another provider — we're pioneering ethical access to regenerative medicine through Right-to-Try pathway, backed by IRB oversight & grounded in real science.
We're the only company offering access to stem cell treatments through the Right-to-Try pathway, giving families an opportunity to pursue innovative regenerative therapies when traditional options are exhausted and no FDA-approved treatments exist for their condition.
The Right-to-Try law allows patients to access investigational biologics that have completed initial safety testing (Phase I) but are not yet fully FDA-approved, expanding access beyond clinical trials and standard care models.
We matched that access with ethical oversight — all of our therapeutic protocols operate under IRB-approved frameworks that protect patient safety, uphold ethical standards, and ensure transparency throughout care.
Autism Spectrum Disorder (ASD) isn't a checkbox behavior; it's a whole-body biological condition. At BetterStem, we pioneered a 360° ASD care model that goes far beyond symptom management:
By evaluating all of these systems together, not in isolation, we design regenerative protocols that address—not just mask—the underlying biology that impacts development, behavior, and quality of life.
We exist to disrupt decades of conventional ASD care that focused almost exclusively on behavior and therapy. With regenerative medicine — including stem cells and biologic modulators — we move toward root-based biology that can support the nervous system, immune balance, and adaptive function in ways traditional therapies can't.
This isn't trend-chasing: it's applying decades of cellular biology and inflammation science to real human problems with real biology at the center.
Clinicians can study autism — but many of us at BetterStem have also lived it. We are parents, siblings, caregivers who have walked this journey with our loved ones.
Our real-world experience shapes every question we ask, every protocol we design, and the way we partner with families. We treat every patient as we would our own — with care, compassion, and unwavering respect.
We provide pathways many clinics don't — helping eligible families access the same investigational stem cell therapies being studied in clinical trials for autism when no approved options remain.
Independent ethical oversight ensures safety, consent, and scientific rigor — not marketing copy.
Our treatments use umbilical cord-derived mesenchymal stem cells from a laboratory partner that has completed FDA-regulated Phase I safety studies, incorporated into protocols designed to support immune balance, reduce inflammation, and help with neural regeneration."
We assess the whole child — from gut health to neuroimmune communication to metabolic resilience — and tailor therapies accordingly.
BetterStem exists because families deserve real options — not vague promises. We are committed to safe, transparent, and biologically grounded care that expands access to regenerative medicine, backed by oversight and grounded in science.
If you're seeking treatments beyond the status quo — with ethical safeguards and a team that truly gets it — you've arrived at the right place.
Start Your JourneyGet answers to common questions about our treatments, process, and what to expect on your journey to pain-free living.
